Drugs / Etecavir
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05203055 Background | Dec 2021 → Dec 2022 | chronic hepatitis B virus infection | Fuzhou General Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Etecavir | “Etecavir 0.5mg qd or Tenofovir 300mg qd” NCT05203055 ↗ |